Abstract:
PURPOSE: Provided are novel adenine compounds which inhibit the cyclin dependent kinase (CDK), specifically, isopropylpurine derivatives with the substitution at C-2,6,9 positions and their preparation method. These adenine compounds are more effective than existing olomousine and roscovitine in CDK inhibition. CONSTITUTION: The compounds are represented by chemical formula 1, wherein R1 is piperidino, piperazino, pyrrolidino or thiomorpholino group which is substituted by one or more groups selected from hydroxyalkyl amino, hydroxy, hydroxyalkyl, carboxylic acid, aldehyde and oxim group. Most preferably R1 is hydroxyalkylamino or 4-carboxy-2-hydroxymethyl pyrrolidino group. The preparation process includes the steps of: reacting 2,6-dichloropurine with 3-chloroaniline in butanol solution; reacting the resultant compound with isopropyl halide in the presence of strong base and reacting the product, in 4:1 mixed solvent of n-butanol and DMSO, with piperidine, piperazino, pyrrolidino or thiomorpholino group which is substituted by one or more group selected from hydroxyalkyl amino, hydroxy, hydroxyalkyl, carboxylic acid, aldehyde and oxim group.
Abstract:
PURPOSE: An arylpiperazine compound and a producing method thereof are provided. The arylpiperazine compound can label technetium and F-18 with no having disadvantages of prior arts. CONSTITUTION: The arylpiperazine compound is represented by formula (1), in which R is methanesulfonyl, paratoluenesulfonyl or trifluoromethanesulfonyl. A compound of formula (1a) is produced by treating a compound of formula (7) with mesyl chloride under triethylamine. A compounds of formula (1b) is produced by reacting a compound of formula (13) with sodium hydrogen and the compound of formula (7) to produce a compound of formula (14); and dissolving the compound of formula (14) in anhydrous anisole and reacting with anhydrous trifluoro acetic acid, in which the compound of formula (13) is produced by dissolving a compound of formula (9) into trifluoro acetic acid and reacting with triphenylmethanol to produce a compound of formula (10); reacting the compound of formula (10) with triethylamine and bromoacetyl bromide to produce a compound of formula (11); reacting the compound of formula (11) with triphenylmethanol under trifluoro acetic acid to produce a compound of formula (12); and reacting the compound of formula (12) with 3-bromopropionyl chloride. The formula (1b), (9) to (14) are described as in the description.
Abstract:
본 발명은 유기 아민의 아실화 방법에 있어서, 아실화제로서 다음 화학식 1을 갖는 N,N-디아실이미다졸론 유도체를 사용하는 아실화 방법을 제공한다: 화학식 1.
식 중에서, R 1 과 R 2 는 같거나 다르고, 메틸, 에틸 또는 C 3 -C 19 의 직쇄 또는 치환된 알킬기, 페닐, 헤테로 사이클릭 화합물, 알콕시기 및 유기산 치환기로 이루어진 군 중에서 선택되며; R 3 와 R 4 는 같거나 다르고, 수소 원자, 메틸 또는 에틸, 페닐, 치환된 페닐 및 알콕시카보닐기로 이루어진 군 중에서 선택되거나, R 3 와 R 4 는 이들이 결합되어 있는 탄소 원자와 함께 다음 구조를 갖는 R 치환 벤젠 고리를 형성함
Abstract:
본 발명은 1단계 또는 2단계 반응에 의한 의학 진단용 시약인 (RR/SS)-4, 8-디아지-3, 6, 6, 9- 테트라 메틸 운데칸-3, 8-디엔-2, 10-디온 비스 옥심의 제조방법에 관한 것이다. 본 발명에 의해 d, 1-HM-PAO가 효과적으로 얻어질 수 있다.
Abstract:
본 발명은 하기 화학식 1로 표시되는 디플루오로페닐 유도체를 갖는 신규한 옥사졸리디논 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 하는 항생제 조성물에 관한 것으로, 본 발명에 따른 조성물에 유효성분으로 함유되는 옥사졸리디논 유도체 및 이의 약학적으로 허용가능함 염은 헤모필루스 인플루엔자(Haemophilus influenza), 비병원성 포도상구균(Coagulase negative staphylococi) 등을 포함하는 그람양성균 및 반코마이신 내성 장내구균(VRE) 등을 포함하는 내성 균주들에 대하여 유의한 항균 활성을 나타내므로, 항생제로서 유용하게 사용될 수 있다. [화학식 1] . (상기 화학식 1에서, R은 본 명세서에서 정의한 바와 같다.) 옥사졸리디논, 리네졸리드, 스피로[2,4]헵탄, MRSA, 반코마이신내성균
Abstract:
A manufacturing method for manufacturing a 2-deoxy-2-[18F]fluoro-5-methyl-1-beta-L-arabinofuranosyluracil compound is provided to produce a compound having high intake rate by specifically activating in a cell line which HSV-TK gene is specifically expressed. A 2-deoxy-2-[18F]fluoro-5-methyl-1-beta-L-arabinofuranosyluracil compound is denoted by the chemical formula 1. A method for manufacturing the 2-deoxy-2-[18F]fluoro-5-methyl-1-beta-L-arabinofuranosyluracil compound comprises: a step of reacting anhydrous trifluoro methanesulfonyl in a compound of the chemical formula 2 under the presence of organic solvent to produce the tribenzoyl triflate saccharide compound of the chemical formula 3; a step of introducing fluorine-18 to produce a compound of the chemical formula 4; a step of reacting the compound of the chemical formula 4 with anhydrous acetic acid under the presence of organic solvent to produce a compound of the chemical formula 5; a step of reacting the compound of the chemical formula 5 with silylated thymine to produce a compound of the chemical formula 7; and a step of hydrolyzing the compound of the chemical formula 7 to produce the compound of the chemical formula 1.
Abstract:
PURPOSE: A method of growing bean sprouts with a bean sprout growing apparatus for sterilizing or disinfecting collected cultivation water with a disinfectant, coagulating pollutants or impurities contained in the cultivation water with a coagulant and an coagulant aid and purifying cultivation water with a bottom-up sand filter layer is provided. The bean growing method can recycle the purified cultivation water, thereby reducing production cost and preventing environmental pollution. CONSTITUTION: The bean sprouts growing method consists of: collecting cultivation water containing pollutants or impurities discharged from a bean sprouts cultivation part; sterilizing or disinfecting cultivation water by adding a disinfectant to the collected cultivation water; coagulating the pollutant or impurities by inputting a coagulant and an coagulant aid to the sterilized cultivation water; purifying cultivation water containing coagulated sludge by passing through a sand filter layer(5,6) from the lower part to the upper part; and resupplying the purified cultivation water to the bean sprouts cultivation part. The disinfectant is 0.5 to 5ppm chlorine dioxide. The coagulant is at least one selected from polyaluminum chloride or polyacrylamide and the coagulant aid is at least one selected from clay, loess, kaolin, vermiculite, active carbon, carbonized rice hull, carbonized rice hull ash, quicklime, K2CO3 and KOH.
Abstract:
PURPOSE: Antibacterial carbapenem derivatives which are active against resistant strains are provided. They are pyrrolidine thiol carbapenems represented by formula(1), wherein R1 is hydrogen, substituted or unsubstituted lower alkly, heterocycles containing N or S, sulfonyl substituted with lower alkyl, carbonyl substituted with heterocycles containing N or S, benzyl, amide or hydroxy group; R2 is hydrogen, hydroxy alkyl, amide or ester group. CONSTITUTION: The method of preparation comprises: reacting phosphate compound with thiol derivatives represented by formula(2) under base and obtaining protected carbapenem derivatives; de-protecting them using hydrogen and palladium as a catalyst; and purifying with porous resin and freeze drying. In formula (2), R1 and R2 are same as in formula(1) and PNZ is p-nitrobenzyloxycarbonyl group.